---
figid: PMC10506516__fnut-10-1214734-g006
figtitle: Schematics of proposed pathway for beneficial effects of L-carnitine on
  lipid parameters
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10506516
filename: PMC10506516__fnut-10-1214734-g006.jpg
figlink: /pmc/articles/PMC10506516/figure/F6
number: F6
caption: Schematics of proposed pathway for beneficial effects of L-carnitine on lipid
  parameters. L-carnitine enhanced the mitochondrial oxidation (beta-oxidation) of
  long Chain-Acyl CoA. Carnitine can reduce the availability of free fatty acids (FFAs),
  diminish conversion of FFAs to triglycerides. L-carnitine can affect cholesterol
  synthesis pathway (mevalonate pathway) via inhibition of β-hydroxy β-methylglutaryl
  (HMG)-CoA reductase activity. Carnitine can improve lipid profile by modifying the
  expression of genes associated with lipid metabolism signaling including peroxisome
  proliferator activated receptor (PPAR α & γ), and peroxisome proliferator-activated
  receptor γ coactivator 1α (PGC-1α). Also, carnitine can protect LDLs from oxidative
  stress and promotes the synthesis of HDL via increment in Apo-A1 level. Carnitine
  Acylcarnitine translocase (CACT); Carnitine palmitoyi transferase II (CPT2); Carnitine
  palmitoyi transferase I (CPT1); Long Acyl-CoA synthetase (LACS).
papertitle: 'The effect of L-carnitine supplementation on lipid profile in adults:
  an umbrella meta-analysis on interventional meta-analyses'
reftext: Vali Musazadeh, et al. Front Nutr. 2023;10(NA):1214734.
year: '2023'
doi: 10.3389/fnut.2023.1214734
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: L-Carnitine | lipid profile | dyslipidemia | umbrella meta-analysis | systematic
  reviews
automl_pathway: 0.9398367
figid_alias: PMC10506516__F6
figtype: Figure
redirect_from: /figures/PMC10506516__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10506516__fnut-10-1214734-g006.html
  '@type': Dataset
  description: Schematics of proposed pathway for beneficial effects of L-carnitine
    on lipid parameters. L-carnitine enhanced the mitochondrial oxidation (beta-oxidation)
    of long Chain-Acyl CoA. Carnitine can reduce the availability of free fatty acids
    (FFAs), diminish conversion of FFAs to triglycerides. L-carnitine can affect cholesterol
    synthesis pathway (mevalonate pathway) via inhibition of β-hydroxy β-methylglutaryl
    (HMG)-CoA reductase activity. Carnitine can improve lipid profile by modifying
    the expression of genes associated with lipid metabolism signaling including peroxisome
    proliferator activated receptor (PPAR α & γ), and peroxisome proliferator-activated
    receptor γ coactivator 1α (PGC-1α). Also, carnitine can protect LDLs from oxidative
    stress and promotes the synthesis of HDL via increment in Apo-A1 level. Carnitine
    Acylcarnitine translocase (CACT); Carnitine palmitoyi transferase II (CPT2); Carnitine
    palmitoyi transferase I (CPT1); Long Acyl-CoA synthetase (LACS).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPARA
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - HMGCR
  - ATP8A2
  - APRT
  - MFAP1
  - ACSL1
  - CPT2
  - CPT1B
  - SLC25A20
  - Acetyl-CoA
  - Acetoacetyl-CoA
  - HDL
  - HMG-CoA
  - ROS
  - Cholesterol
  - LDL
  - Triglyceride
  - FFA
  - Carnitine
  - COASH
---
